Oligon
2 known investors
Find your way into Oligon
Oligon Therapeutics develops RNA-based multi-targeting drugs using its SeekR platform, which combines RNA aptamer oligo-binders with siRNA silencers into a single self-delivering molecule for precise targeting of specific cell types, including T-cells and cancer cells. The biotechnology company applies AI-based molecular modeling to discover and optimize these RNA drug candidates.
Founders & leadership
SM
Spyro MoussesinCo-Founder
Investors · 2
In the news
Frequently asked questions
- What does Oligon do?
- Oligon Therapeutics develops RNA-based multi-targeting drugs using its SeekR platform, which combines RNA aptamer oligo-binders with siRNA silencers into a single self-delivering molecule for precise targeting of specific cell types, including T-cells and cancer cells. The biotechnology company applies AI-based molecular modeling to discover and optimize these RNA drug candidates.
- Who founded Oligon?
- Oligon was founded by Spyro Mousses.
- Who are Oligon's investors?
- Oligon's investors include CTI Life Sciences Fund L.P., Fonds de solidarité FTQ.